{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:48:54Z","timestamp":1756464534214},"reference-count":77,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2023,10,3]]},"DOI":"10.1080\/14740338.2023.2254699","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T10:52:26Z","timestamp":1693911146000},"page":"897-908","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Safety of PARP inhibitors as maintenance therapy in ovarian cancer"],"prefix":"10.1080","volume":"22","author":[{"given":"Sabrina Chiara","family":"Cecere","sequence":"first","affiliation":[{"name":"Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Casartelli","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, University Hospital of Parma, Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Forte","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, Division of Medical Oncology, University of Campania Luigi Vanvitelli, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"Pignata","sequence":"additional","affiliation":[{"name":"Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela","family":"Pisano","sequence":"additional","affiliation":[{"name":"Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,9,14]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.21037\/cco-20-34"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21254"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19031106"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2021.102045"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-1683"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22084203"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19148577"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30786-1"},{"key":"e_1_3_6_11_1","unstructured":"Pal R. PARP inhibitors: where are we in 2020 and what\u2019s coming next? - Crown bioscience. 2020. https:\/\/blog.crownbio.com\/parp-inhibitors-2020"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1909707"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-021-03714-w"},{"key":"e_1_3_6_14_1","unstructured":"European Medicines Agency (EMA). Lynparza. 2022 Oct 10. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/lynparza"},{"key":"e_1_3_6_15_1","unstructured":"European Medicines Agency (EMA). Rubraca. 2022 Dec 8. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/rubraca"},{"key":"e_1_3_6_16_1","unstructured":"European Medicines Agency (EMA). 2022 Aug 9. Zejula. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/zejula"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2015.07.019"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2014.202"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.3892\/or.2021.8231"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.564601"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19138113"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14163888"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx441"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.12636"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-015-2836-2"},{"key":"e_1_3_6_26_1","unstructured":"Food and Drug Administration (FDA). lynparza. highlights of prescribing information. 2022 Sep 7. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/208558s023lbl.pdf"},{"key":"e_1_3_6_27_1","unstructured":"Food and Drug Administration (FDA). Rubraca. highlights of prescribing information. 2022 Sep 7. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/209115s003lbl.pdf"},{"key":"e_1_3_6_28_1","unstructured":"Food and Drug Administration (FDA). Zejula. highlights of prescribing information. 2022 Sep 7. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/208447s015s017lbledt.pdf"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S387920"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32440-6"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.575"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2017.05.025"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611310"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2022.07.005"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911361"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1810858"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910962"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100558"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00531-3"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01549"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01003"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30469-2"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S164553"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.12.018"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.573801"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.21037\/atm-21-1883"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.815265"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000001144"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2021.03.011"},{"key":"e_1_3_6_50_1","first-page":"A312","article-title":"2022 RA-1237-ESGO predictors of PARP inhibitors toxicities and the toxicity impact on overall survival in advanced ovarian cancer","volume":"32","author":"Silva Lima JMD","year":"2022","unstructured":"Silva Lima JMD, Rodriguez MG, Garrido A, et al. 2022 RA-1237-ESGO predictors of PARP inhibitors toxicities and the toxicity impact on overall survival in advanced ovarian cancer. Int J Gynecologic Cancer. 2022;32:A312.","journal-title":"Int J Gynecologic Cancer"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2022.07.022"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13349"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy181"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(16)32967-7"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-001288"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01924"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.1513"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.60"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29615"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30360-4"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2022.11.027"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2022.08.021"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-8258(21)00693-4"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00073-5"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab362"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.912256"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b00990"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-18-0138"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30061-9"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2018.01.010"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0268"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2018.01.011"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21456"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2022.01.024"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.10.007"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2018.12.009"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2022-003614"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00139-5"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.3390\/proteomes10020016"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2023.2254699","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T12:57:36Z","timestamp":1695301056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2023.2254699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,14]]},"references-count":77,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10,3]]}},"alternative-id":["10.1080\/14740338.2023.2254699"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2023.2254699","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-03-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}